High-Dose Intermittent Treatment with the Multikinase tor Sunitinib Leads to High Intra-Tumor Drug Exposure ients with Advanced Solid Tumors

Thumbnail
Fulltext:
288213.pdf
Size:
1.236Mb
Format:
PDF
Description:
Publisher’s version
Download
Publication year
2022
Author(s)
Gerritse, S.L.
Labots, M.
Heine, R. ter
Dekker, H.
Poel, D.
Tauriello, D.V.F.
Nagtegaal, I.D.
Hombergh, E.C.A. van den
Erp, N.P. van
Verheul, H.M.W.
Source
Cancers, 14, 24, (2022), article 6061
ISSN
DOI
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/288213   https://hdl.handle.net/2066/288213
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.